Hofmann, M.; Kunte, S.C.; Unterrainer, M.; Delker, A.; Holzgreve, A.; Toms, J.; Gildehaus, F.J.; Auernhammer, C.J.; Spitzweg, C.; Zacherl, M.J.;
et al. Comparison of the Hematotoxicity of PRRT with Lutathera® and Locally Manufactured 177Lu-HA-DOTATATE in Patients with Neuroendocrine Tumors and the Impact of Different Application Intervals. Cancers 2025, 17, 1423.
https://doi.org/10.3390/cancers17091423
AMA Style
Hofmann M, Kunte SC, Unterrainer M, Delker A, Holzgreve A, Toms J, Gildehaus FJ, Auernhammer CJ, Spitzweg C, Zacherl MJ,
et al. Comparison of the Hematotoxicity of PRRT with Lutathera® and Locally Manufactured 177Lu-HA-DOTATATE in Patients with Neuroendocrine Tumors and the Impact of Different Application Intervals. Cancers. 2025; 17(9):1423.
https://doi.org/10.3390/cancers17091423
Chicago/Turabian Style
Hofmann, Markus, Sophie C. Kunte, Marcus Unterrainer, Astrid Delker, Adrien Holzgreve, Johannes Toms, Franz Joseph Gildehaus, Christoph J. Auernhammer, Christine Spitzweg, Mathias J. Zacherl,
and et al. 2025. "Comparison of the Hematotoxicity of PRRT with Lutathera® and Locally Manufactured 177Lu-HA-DOTATATE in Patients with Neuroendocrine Tumors and the Impact of Different Application Intervals" Cancers 17, no. 9: 1423.
https://doi.org/10.3390/cancers17091423
APA Style
Hofmann, M., Kunte, S. C., Unterrainer, M., Delker, A., Holzgreve, A., Toms, J., Gildehaus, F. J., Auernhammer, C. J., Spitzweg, C., Zacherl, M. J., Ilhan, H., Rübenthaler, J., Beyer, L., & Unterrainer, L. M.
(2025). Comparison of the Hematotoxicity of PRRT with Lutathera® and Locally Manufactured 177Lu-HA-DOTATATE in Patients with Neuroendocrine Tumors and the Impact of Different Application Intervals. Cancers, 17(9), 1423.
https://doi.org/10.3390/cancers17091423
